Option Care Health (NASDAQ:OPCH) Cut to Neutral at Bank of America

Bank of America lowered shares of Option Care Health (NASDAQ:OPCH) from a buy rating to a neutral rating in a research note released on Wednesday morning, MarketBeat.com reports. They currently have $29.00 target price on the stock, down from their previous target price of $43.00.

Other equities research analysts have also recently issued research reports about the stock. Barrington Research restated an “outperform” rating and issued a $40.00 price objective on shares of Option Care Health in a research report on Wednesday, October 23rd. JMP Securities raised their target price on shares of Option Care Health from $36.00 to $37.00 and gave the company a “market outperform” rating in a research note on Monday, September 30th. Two analysts have rated the stock with a hold rating and three have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, Option Care Health has an average rating of “Moderate Buy” and an average target price of $31.60.

Option Care Health Trading Up 4.6 %

Shares of Option Care Health stock opened at $24.11 on Wednesday. The firm has a market capitalization of $4.10 billion, a PE ratio of 20.26, a price-to-earnings-growth ratio of 1.79 and a beta of 1.32. The company has a debt-to-equity ratio of 0.77, a current ratio of 1.73 and a quick ratio of 1.36. The company’s fifty day moving average price is $30.49 and its two-hundred day moving average price is $29.92. Option Care Health has a 52-week low of $22.84 and a 52-week high of $34.63.

Option Care Health (NASDAQ:OPCH) last posted its quarterly earnings data on Wednesday, October 30th. The company reported $0.36 earnings per share for the quarter, beating the consensus estimate of $0.31 by $0.05. The firm had revenue of $1.28 billion during the quarter, compared to analysts’ expectations of $1.22 billion. Option Care Health had a net margin of 4.37% and a return on equity of 15.30%. On average, analysts expect that Option Care Health will post 1.22 EPS for the current year.

Insider Activity

In related news, CFO Michael H. Shapiro sold 23,217 shares of Option Care Health stock in a transaction that occurred on Thursday, August 22nd. The shares were sold at an average price of $30.95, for a total transaction of $718,566.15. Following the transaction, the chief financial officer now owns 247,317 shares of the company’s stock, valued at $7,654,461.15. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. In other Option Care Health news, CFO Michael H. Shapiro sold 23,217 shares of the firm’s stock in a transaction that occurred on Thursday, August 22nd. The shares were sold at an average price of $30.95, for a total transaction of $718,566.15. Following the sale, the chief financial officer now directly owns 247,317 shares in the company, valued at approximately $7,654,461.15. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, Director Elizabeth Quadros Betten sold 47,531 shares of the firm’s stock in a transaction that occurred on Wednesday, August 21st. The stock was sold at an average price of $31.09, for a total transaction of $1,477,738.79. Following the sale, the director now owns 21,339 shares in the company, valued at $663,429.51. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 0.64% of the company’s stock.

Institutional Trading of Option Care Health

Hedge funds and other institutional investors have recently made changes to their positions in the business. UMB Bank n.a. raised its holdings in shares of Option Care Health by 937.5% in the third quarter. UMB Bank n.a. now owns 830 shares of the company’s stock valued at $26,000 after purchasing an additional 750 shares during the last quarter. GAMMA Investing LLC boosted its position in Option Care Health by 110.6% during the third quarter. GAMMA Investing LLC now owns 897 shares of the company’s stock worth $28,000 after purchasing an additional 471 shares during the period. Whittier Trust Co. of Nevada Inc. boosted its position in shares of Option Care Health by 3,362.8% in the third quarter. Whittier Trust Co. of Nevada Inc. now owns 1,489 shares of the company’s stock valued at $47,000 after acquiring an additional 1,446 shares during the period. SageView Advisory Group LLC bought a new stake in shares of Option Care Health in the first quarter valued at about $85,000. Finally, International Assets Investment Management LLC lifted its position in Option Care Health by 3,029.7% during the third quarter. International Assets Investment Management LLC now owns 2,848 shares of the company’s stock worth $91,000 after purchasing an additional 2,757 shares during the period. 98.05% of the stock is currently owned by institutional investors and hedge funds.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.